483 Watson Pharmaceuticals Mar 2009

483 Watson Pharmaceuticals Mar 2009

Carla Lundi FDA$119.00 - Available Now

FDA investigators audited the Watson Pharmaceuticals - Corona, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 23 Mar 2009.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 23 Mar 2009
  • Location: Corona, United States
  • FEI: 3003944123
Add To Cart